242 related articles for article (PubMed ID: 30972627)
1. Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia.
Maes M; Sirivichayakul S; Kanchanatawan B; Vodjani A
Mol Neurobiol; 2019 Oct; 56(10):7056-7073. PubMed ID: 30972627
[TBL] [Abstract][Full Text] [Related]
2. Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia.
Maes M; Sirivichayakul S; Kanchanatawan B; Vodjani A
Neurotox Res; 2019 Aug; 36(2):306-322. PubMed ID: 31077000
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways.
Maes M; Vojdani A; Geffard M; Moreira EG; Barbosa DS; Michelin AP; Semeão LO; Sirivichayakul S; Kanchanatawan B
Biomol Concepts; 2019 Nov; 10(1):209-225. PubMed ID: 31734647
[TBL] [Abstract][Full Text] [Related]
4. In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype.
Maes M; Kanchanatawan B; Sirivichayakul S; Carvalho AF
Neurotox Res; 2019 Apr; 35(3):684-698. PubMed ID: 30552634
[TBL] [Abstract][Full Text] [Related]
5. In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity.
Maes M; Andrés-Rodríguez L; Vojdani A; Sirivichayakul S; Barbosa DS; Kanchanatawan B
CNS Neurol Disord Drug Targets; 2023; 22(2):215-225. PubMed ID: 35946099
[TBL] [Abstract][Full Text] [Related]
6. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
Mol Neurobiol; 2018 Mar; 55(3):2214-2226. PubMed ID: 28290151
[TBL] [Abstract][Full Text] [Related]
7. Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach.
Maes M; Sirivichayakul S; Matsumoto AK; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Carvalho AF; Solmi M; Kanchanatawan B
Mol Neurobiol; 2020 Nov; 57(11):4578-4597. PubMed ID: 32754898
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia.
Maes M; Vojdani A; Sirivichayakul S; Barbosa DS; Kanchanatawan B
Mol Neurobiol; 2021 Jul; 58(7):3319-3334. PubMed ID: 33675500
[TBL] [Abstract][Full Text] [Related]
9. IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety.
Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
CNS Neurol Disord Drug Targets; 2017; 16(4):472-483. PubMed ID: 28403801
[TBL] [Abstract][Full Text] [Related]
10. Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia.
Kanchanatawan B; Sriswasdi S; Maes M
Metab Brain Dis; 2019 Feb; 34(1):267-282. PubMed ID: 30467771
[TBL] [Abstract][Full Text] [Related]
11. A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.
Sirivichayakul S; Kanchanatawan B; Thika S; Carvalho AF; Maes M
CNS Neurol Disord Drug Targets; 2019; 18(2):124-140. PubMed ID: 30451122
[TBL] [Abstract][Full Text] [Related]
12. In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study.
Kanchanatawan B; Thika S; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
Neurotox Res; 2018 Apr; 33(3):641-655. PubMed ID: 29380275
[TBL] [Abstract][Full Text] [Related]
13. In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde.
Maes M; Sirivichayakul S; Kanchanatawan B; Carvalho AF
World J Biol Psychiatry; 2020 Jun; 21(5):383-401. PubMed ID: 32031479
[No Abstract] [Full Text] [Related]
14. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis.
Ciccia F; Guggino G; Rizzo A; Alessandro R; Luchetti MM; Milling S; Saieva L; Cypers H; Stampone T; Di Benedetto P; Gabrielli A; Fasano A; Elewaut D; Triolo G
Ann Rheum Dis; 2017 Jun; 76(6):1123-1132. PubMed ID: 28069576
[TBL] [Abstract][Full Text] [Related]
15. Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.
Kanchanatawan B; Hemrungrojn S; Thika S; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
Mol Neurobiol; 2018 Jun; 55(6):5184-5201. PubMed ID: 28875464
[TBL] [Abstract][Full Text] [Related]
16. IgM-mediated autoimmune responses to oxidative specific epitopes, but not nitrosylated adducts, are significantly decreased in pregnancy: association with bacterial translocation, perinatal and lifetime major depression and the tryptophan catabolite (TRYCAT) pathway.
Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
Metab Brain Dis; 2017 Oct; 32(5):1571-1583. PubMed ID: 28600633
[TBL] [Abstract][Full Text] [Related]
17. How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia.
Maes M; Vojdani A; Galecki P; Kanchanatawan B
Brain Sci; 2020 Sep; 10(9):. PubMed ID: 32957709
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
Kanchanatawan B; Maes M
CNS Neurol Disord Drug Targets; 2018; 17(6):473-486. PubMed ID: 29968545
[TBL] [Abstract][Full Text] [Related]
19. In Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome.
Maes M; Kanchanatawan B; Sirivichayakul S; Carvalho AF
Mol Neurobiol; 2019 Jul; 56(7):5122-5135. PubMed ID: 30484113
[TBL] [Abstract][Full Text] [Related]
20. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.
Kanchanatawan B; Sirivichayakul S; Carvalho AF; Anderson G; Galecki P; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):205-216. PubMed ID: 28690204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
